SCHEMBL6486922

SCHEMBL6486922

COP(=O)(CC(=O)c1cccc(OCCOC(C)(C)C)c1)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
SMPD1 P17405 3/20 0.41
THRB P10828 2/20 0.40
THRA P10827 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 1/20 0.40
LMNA P02545 2/20 0.40
POLB P06746 2/20 0.40
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
NR1H4 Q96RI1 2/20 0.38
ALDH1A1 P00352 1/20 0.38
NR4A1 P22736 1/20 0.38
NR4A2 P43354 1/20 0.38
NR4A3 Q92570 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5734264 0.84 SMPD1 (0.55) KMT2ASMPD1THRBTHRAMAPT
SCHEMBL6486933 0.82 KMT2A (0.43) KMT2ASMPD1THRBTHRASMN1; SMN2
SCHEMBL5733413 0.82 RAB9A (0.52) KMT2ASMN1; SMN2MAPTLMNAPOLB
SCHEMBL5734492 0.81 NR1H4 (0.48) KMT2ASMPD1SMN1; SMN2LMNAPOLB
SCHEMBL5732667 0.80 CES2 (0.57) KMT2ASMN1; SMN2LMNAPOLBMEN1
SCHEMBL6490447 0.78 MAOB (0.63) KMT2ASMPD1MEN1NR1H4NR4A1
SCHEMBL5733091 0.77 ERCC5 (0.57) KMT2ASMN1; SMN2LMNAPOLBMEN1
SCHEMBL5733759 0.75 KDM4E (0.55) SMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL5733382 0.74 NR4A2 (0.64) KMT2ALMNAMEN1NR4A1NR4A2
SCHEMBL5732822 0.74 POLB (0.69) KMT2ASMN1; SMN2LMNAPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6900336-B2 8-aza-11-deoxy prostaglandin analogues SYNTEX (U.S.A.) LLC (US) 2005-05-31 US disclosed
US-20030120079-A1 Such as 7-((R)-2-((E)-3-(3-Benzyl-phenyl)-3-hydroxy-propenyl)-5-oxo-pyrrolidin-1-yl)-heptanoic acid; side effects reduction SYNTEX (U.S.A.) LLC 2003-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030120079-A1 Such as 7-((R)-2-((E)-3-(3-Benzyl-phenyl)-3-hydroxy-propenyl)-5-oxo-pyrrolidin-1-yl)-heptanoic acid; side effects reduction PTGER4, FFAR4, PTGER1 KMT2A 3518/4885SMPD1 2894/4885THRB 494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.